Rovatirelin


CAS No. : 204386-76-5

Rovatirelin,204386-76-5
Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I009190
Synonyms:Rovatirelin; S-0373; S 0373; S0373.;(4S,5S)-5-methyl-N-((S)-1-((R)-2-methylpyrrolidin-1-yl)-1-oxo-4-(thiazol-4-yl)butan-2-yl)-2-oxooxazolidine-4-carboxamide
Molecular Formula:C16H22N4O4S
Molecular Weight:366.436
Price:Get quote
We would like to match the lowest price on market if possible.

Your information is safe with us.

refresh
Appearance:Solid Powder
Purity:98%
Cat No:I009190
Cas No:204386-76-5
Product-Name:Rovatirelin
IUPAC Name:(4S,5S)-5-methyl-N-[(2S)-1-[(2R)-2-methylpyrrolidin-1-yl]-1-oxo-3-(1,3-thiazol-4-yl)propan-2-yl]-2-oxo-1,3-oxazolidine-4-carboxamide
InChI:InChI=1S/C16H22N4O4S/c1-9-4-3-5-20(9)15(22)12(6-11-7-25-8-17-11)18-14(21)13-10(2)24-16(23)19-13/h7-10,12-13H,3-6H2,1-2H3,(H,18,21)(H,19,23)/t9-,10+,12+,13+/m1/s1
InChIKey:WTXWDXWZGJGIHV-URBCHYCLSA-N
SMILES:CC1CCCN1C(=O)C(CC2=CSC=N2)NC(=O)C3C(OC(=O)N3)C
Rovatirelin, also known as S-0373, is a novel synthetic agent that mimics the actions of thyrotropin-releasing hormone (TRH). Rovatirelin binds to the human TRH receptor with higher affinity (Ki=702nM) than taltirelin (Ki=3877nM). Rovatirelin increased the spontaneous firing of action potentials in the acutely isolated noradrenergic neurons of rat locus coeruleus (LC). Rovatirelin increased locomotor activity. Rovatirelin may have an orally effective therapeutic potential in patients with SCD.
1:Eur J Pharmacol. 2015 Aug 15;761:413-22. doi: 10.1016/j.ejphar.2015.05.047. Epub 2015 Jul 2. Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.Ijiro T,Nakamura K,Ogata M,Inada H,Kiguchi S,Maruyama K,Nabekura J,Kobayashi M,Ishibashi H, PMID: 26142830 DOI: 10.1016/j.ejphar.2015.05.047
Abstract: Rovatirelin ([1-[-[(4S,5S)-(5-methyl-2-oxo oxazolidin-4-yl) carbonyl]-3-(thiazol-4-yl)-l-alanyl]-(2R)-2-methylpyrrolidine) is a novel synthetic agent that mimics the actions of thyrotropin-releasing hormone (TRH). The aim of this study was to investigate the electrophysiological and pharmacological effects of rovatirelin on the central noradrenergic system and to compare the results with those of another TRH mimetic agent, taltirelin, which is approved for the treatment of spinocerebellar degeneration (SCD) in Japan. Rovatirelin binds to the human TRH receptor with higher affinity (Ki=702nM) than taltirelin (Ki=3877nM). Rovatirelin increased the spontaneous firing of action potentials in the acutely isolated noradrenergic neurons of rat locus coeruleus (LC). The facilitatory action of rovatirelin on the firing rate in the LC neurons was inhibited by the TRH receptor antagonist, chlordiazepoxide. Reduction of the extracellular pH increased the spontaneous firing of LC neurons and rovatirelin failed to increase the firing frequency further, indicating an involvement of acid-sensitive K+ channels in the rovatirelin action. In in vivo studies, oral administration of rovatirelin increased both c-Fos expression in the LC and extracellular levels of noradrenaline (NA) in the medial prefrontal cortex (mPFC) of rats. Furthermore, rovatirelin increased locomotor activity. The increase in NA level and locomotor activity by rovatirelin was more potent and longer acting than those by taltirelin. These results indicate that rovatirelin exerts a central nervous system (CNS)-mediated action through the central noradrenergic system, which is more potent than taltirelin. Thus, rovatirelin may have an orally effective therapeutic potential in patients with SCD. Copyright © 2015 Elsevier B.V. All rights reserved.
Recommended Products
  • CAS No. :1346604-36-1
    Product Name:

    N-Acetyl Glyphosate-d3

    Cat No: R053388 View details
  • CAS No. :NA
    Product Name:

    3-Hydroxy-2-[(E)-[(1S,2S,5S)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]hept-3-ylidene]amino]-15-methyl-

    Cat No: R053389 View details
  • CAS No. :1346604-02-1
    Product Name:

    N-Trifluoroacetyl-1,3-propylenediamine Hydrochloride

    Cat No: R053390 View details
  • CAS No. :NA
    Product Name:

    3’,5’-Di-O-tert-butyldimethylsilyl-2’-deoxy-8-[(3-(methyl-d3)-8-methyl-3H-imidazo[4,5-f]quinoxalin-2

    Cat No: R053391 View details